L. Chaudry

The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs.

Stefan Senger, Savvas Kleanthous, Iain M McLay, 2011, Bioorganic & medicinal chemistry letters.

Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor.

C. Davies, D. Johns, Y. Matsuoka, 2015, Antioxidants & redox signaling.

IMMUNOREACTIVE HUMAN CHORIONIC GONADOTROPHIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA

T. Chard, D. Lowe, P. Coates, 1988, Clinical Endocrinology.

Antithrombotic Potential of GW813893: A Novel, Orally Active, Active-site Directed Factor Xa Inhibitor

P. Zhou, David Brown, Chuen Chan, 2008, Journal of cardiovascular pharmacology.

Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitors.

Stefan Senger, Matthew Campbell, Andrew R Leach, 2006, Bioorganic & medicinal chemistry letters.

Release of arachidonic acid and the effects of corticosteroids on steroidogenesis in rat testis Leydig cells

B. Cooke, D. Abayasekara, L. Chaudry, 1991, The Journal of Steroid Biochemistry and Molecular Biology.

Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket

R. Grimley, R. Solari, J. Harling, 2013, The Journal of Biological Chemistry.

Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor.

Y. Matsuoka, V. Jaquet, Jean Lim, 2015, Antioxidants & redox signaling.